Mavyret Pellet
Product Images NDC 0074-2600

9 FDA label images from Abbvie Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Mavyret (NDC 0074-2600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glecaprevir (Mavyret Spl 01)

Glecaprevir (Mavyret Spl 01)
Chemical structure of Glecaprevir, one of the active ingredients in Mavyret (Glecaprevir and Pibrentasvir), depicted with stereochemistry and hydration (X H2O).*
FDA Label Image

Pibrentasvir (Mavyret Spl 02)

Pibrentasvir (Mavyret Spl 02)
Chemical structure diagram of Glecaprevir, one of the active ingredients in Mavyret tablets. The diagram depicts the molecular structure including rings, fluorine atoms, methyl groups, and stereochemistry.*
FDA Label Image

Instructions For Use (Mavyret Spl 03)

Instructions For Use (Mavyret Spl 03)
Mavyret (Glecaprevir and Pibrentasvir) oral medication guide cover page. The label features cartoon figures holding stop signs and instructs patients to read the entire medication guide before use. It includes manufacturer details for AbbVie Inc. and a QR code. The design is mainly white with red and orange accents.*
FDA Label Image

Instructions For Use (Mavyret Spl 04)

Instructions For Use (Mavyret Spl 04)
An illustrated step-by-step guide showing how to prepare and administer Mavyret (Glecaprevir and Pibrentasvir) medication by mixing pellets with food. It includes instructions for finding the correct number of packets, choosing soft foods that stick to the spoon, preparing the dose, adding pellets, mixing well, and administering the medication with safety precautions and contact information for questions.*
FDA Label Image

Ndc 0074-2625-04rx Onlymavyret®(glecaprevir And Pibrentasvir)100mg / 40mgeach Tablet Contains Glecaprevir And Pibrentasvir 100mg / 40mg.this Carton Contains 21 Tablets Packaged As Follows: 7 Daily Blisters For 1 Week Of Treatment.each Daily Blister Contains 3 Tablets.mon Tue Wed Thu Fri Sat Suntrack Your Daily Treatment By Pushing In The Tab Above After Removing Each Pack From Carton. (Mavyret Spl 05)

Ndc 0074-2625-04rx Onlymavyret®(glecaprevir And Pibrentasvir)100mg / 40mgeach Tablet Contains Glecaprevir And Pibrentasvir 100mg / 40mg.this Carton Contains 21 Tablets Packaged As Follows: 7 Daily Blisters For 1 Week Of Treatment.each Daily Blister Contains 3 Tablets.mon Tue Wed Thu Fri Sat Suntrack Your Daily Treatment By Pushing In The Tab Above After Removing Each Pack From Carton. (Mavyret Spl 05)
Packaging label for Mavyret 100 mg/40 mg film-coated tablets containing Glecaprevir and Pibrentasvir. The label features the AbbVie Inc. logo and includes medication and usage instructions on a predominantly white and orange background, with areas for barcodes and product identification.*
FDA Label Image

Ndc 0074-2625-04 4-week Supplyrx Onlymavyret®(glecaprevir And Pibrentasvir)100mg / 40mgeach Tablet Contains Glecaprevir And Pibrentasvir 100mg / 40mg.this Monthly Carton Contains 84 Tablets Packaged As Follows: 4 Weekly Cartons Of Therapy.each Weekly Carton Contains 21 Tablets In 7 Daily Blisters Of 3 Tablets Each. (Mavyret Spl 06)

Ndc 0074-2625-04   4-week Supplyrx Onlymavyret®(glecaprevir And Pibrentasvir)100mg / 40mgeach Tablet Contains Glecaprevir And Pibrentasvir 100mg / 40mg.this Monthly Carton Contains 84 Tablets Packaged As Follows: 4 Weekly Cartons Of Therapy.each Weekly Carton Contains 21 Tablets In 7 Daily Blisters Of 3 Tablets Each. (Mavyret Spl 06)
Mavyret 100 mg / 40 mg film-coated tablet carton packaging label by AbbVie Inc. The label shows the proprietary name Mavyret with the active ingredients Glecaprevir and Pibrentasvir listed at 100 mg and 40 mg per tablet. The packaging includes barcode and storage instructions, with a distinctive curved yellow and red design element on the front panel. The label also contains required regulatory information and markings.*
FDA Label Image

Ndc 0074-2625-28rx Onlymavyret®(glecaprevir And Pibrentasvir)100mg / 40mgeach Tablet Contains Glecaprevir And Pibrentasvir 100mg / 40mg.this Carton Contains 21 Tablets Packaged As Follows: 7 Wallets For 1 Week Of Treatment.each Wallet Contains 3 Tablets.mon Tue Wed Thu Fri Sat Suntrack Your Daily Treatment By Pushing In The Tab Above After Removing Each Pack From Carton. (Mavyret Spl 07)

Ndc 0074-2625-28rx Onlymavyret®(glecaprevir And Pibrentasvir)100mg / 40mgeach Tablet Contains Glecaprevir And Pibrentasvir 100mg / 40mg.this Carton Contains 21 Tablets Packaged As Follows: 7 Wallets For 1 Week Of Treatment.each Wallet Contains 3 Tablets.mon Tue Wed Thu Fri Sat Suntrack Your Daily Treatment By Pushing In The Tab Above After Removing Each Pack From Carton. (Mavyret Spl 07)
Mavyret 100 mg/40 mg film-coated tablet packaging label for oral use. The label displays the proprietary name Mavyret with the generic names glecaprevir and pibrentasvir. It indicates a 4-week supply, with detailed labeling by AbbVie Inc. The design includes an orange and yellow curved graphic and shows barcodes and text for product identification.*
FDA Label Image

Ndc 0074-2625-28rx Only4-week Supplymavyret®(glecaprevir And Pibrentasvir)100mg / 40mgeach Tablet Contains Glecaprevir And Pibrentasvir 100mg / 40mgthis Monthly Carton Contains 84 Tablets Packaged As Follows: 4 Weekly Cartons Of Therapy.each Weekly Carton Contains 21 Tablets In 7 Wallets Of 3 Tablets Each. (Mavyret Spl 08)

Ndc 0074-2625-28rx Only4-week Supplymavyret®(glecaprevir And Pibrentasvir)100mg / 40mgeach Tablet Contains Glecaprevir And Pibrentasvir 100mg / 40mgthis Monthly Carton Contains 84 Tablets Packaged As Follows: 4 Weekly Cartons Of Therapy.each Weekly Carton Contains 21 Tablets In 7 Wallets Of 3 Tablets Each. (Mavyret Spl 08)
Label of Mavyret 100 mg/40 mg film-coated tablets containing glecaprevir and pibrentasvir. The label indicates prescription use, 84 tablets per package, for institutional use only, with storage instructions and manufacturer AbbVie Inc. information. It includes a barcode and batch details area.*
FDA Label Image

Principal Display Panelndc 0074-2600-28rx Onlymavyret®(glecaprevir/pibrentasivir) Oral Pellets50 mg/20 mgeach Packet Contains Pink And Yellow Oral Pellets.28 Packets (Mavyret Spl 09)

Principal Display Panelndc 0074-2600-28rx Onlymavyret®(glecaprevir/pibrentasivir) Oral Pellets50 mg/20 mgeach Packet Contains Pink And Yellow Oral Pellets.28 Packets (Mavyret Spl 09)
Packaging label for Mavyret 50 mg/20 mg film-coated tablets by AbbVie Inc. The label indicates the active ingredients as glecaprevir and pibrentasvir. The package contains oral packets with each packet having red and yellow oval patterns. Three individual packets are visible alongside the outer carton layout.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.